MK-4074 - Acetyl-CoA Carboxylase 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
MK-4074 - Acetyl-CoA Carboxylase 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
MK-4074 - Acetyl-CoA Carboxylase 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
MK-4074 - Acetyl-CoA Carboxylase 抑制剂 - 生命科学试剂 - MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMK-4074Cat. No.: HY-107709CAS No.: 1039758-22-9分式: CHNO分量: 565.62作靶点: Acetyl-CoA Carboxylase作通路: Metabolic Enzyme/Protease储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 83.3 mg/mL (147.27

2、mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.7680 mL 8.8399 mL 17.6797 mL5 mM 0.3536 mL 1.7680 mL 3.5359 mL10 mM 0.1768 mL 0.8840 mL 1.7680 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 MK-4074酰辅酶A羧化酶 (acetyl-CoA carboxylase) 的肝特异性抑制剂,IC50 值约为3nM。IC

3、50 & Target IC50: 3 nM (Acetyl-CoA Carboxylase) 1体外研究MK-4074 strongly inhibits both ACC1 and ACC2 with IC50 values of approximately 3 nM. MK-4074 is highlyliver specific because it is a substrate of organic anion transport protein (OATP) transporters that are presentonly in hepatocytes, and excretio

4、n of MK-4074 from hepatocytes into bile is dependent on the MRP2 efflux1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEtransporter 1.体内研究 In male KKAy mice, a mouse model of obesity, type 2 diabetes, and fatty liver, a single oral dose of MK-4074(0.3-3 mg/kg) significantly decreases DNL in a dose-d

5、ependent manner with an ID50 value of 0.9 mg/kg 1 hrpost-administration. In a time course study, MK-4074 orally at 30 mg/kg reduces hepatic DNL by 83%, 70%,and 51% at 4, 8, and 12 hr post-dose, respectively. Single oral doses of MK-4074 at 30 and 100 mg/kgsignificantly increases plasma total ketones

6、, a surrogate biomarker for hepatic FAO, by 1.5-fold to 3-fold forup to 8 hr 1.PROTOCOLKinase Assay 1 Recombinant ACC protein is purified from FM3A or Sf9 cells expressing recombinant ACC by chelatingchromatography or from liver by Softlink avidin resin chromatography. Purified ACC protein is incuba

7、ted withMK-4074 in assay buffer containing 5 mM ATP, 250 mM acetyl-CoA, 4.1 mM NaHCO3, 0.086 mMNaH14CO3, 20 mM potassium citrate, 20 mM MgCl2, 2 mM DTT, 0.5 mg/mL BSA and 50 mM HEPES-Na(pH 7.5) for 40 min at 37C 1.MCE has not independently confirmed the accuracy of these methods. They are for refere

8、nce only.Cell Assay 1 For cellular assays of DNL and FAO, cells are pre-incubated with MK-4074 for 1 hr. Then the cells areincubated for additional 1-3 hr with either 65-260 mM 14C-labeled acetate or 0.018 mM 3H-labeled palmitatefor DNL or FAO assay, respectively. After incubation, intracellular 14C

9、-labeled lipids and released 3H-labeledfatty acids are extracted and measured for DNL and FAO, respectively 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Studies are performed in male KKAy mice or C57BL/6J mice. KKAy mi

10、ce are fed a chow diet while C57BL/6Jmice are fed a high-fat diet (45% fat) for 3 weeks prior to study. Mice are treated for 7 days with vehicle(distilled water, 0.2 mL/mouse) before MK-4074 administration to acclimate mice to oral dosing. Animals aredrug naive at the time of study. Mice are housed

11、individually. Male KKAy mice (n=10-11/group) areadministered a single oral dose of MK-4074 (0.3 to 3 mg/kg) prior to liver slice studies. Male KKAy mice(n=5/group) are administered a single oral dose of MK-4074 (3 to 30 mg/kg) prior to measurement of liverDNL rates. Male KKAy mice (n=8/group) are ad

12、ministered a single oral dose of MK-4074 (10 to 100 mg/kg)and plasma ketone bodies are measured at the indicated times. Male C57BL/6J mice (n=5, veh; n=10, MK-4074) are fed chow or a high-fat/high-sucrose (HF/HS) diet for 7 weeks and vehicle or MK-4074 isadministered orally (10 or 30 mg/kg/day) for

13、4 weeks prior to study 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Kim CW, et al. Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: ABedside to Bench Investigation. Cell Metab. 2017 Aug 1;26(2):394-406.e6.McePdfHeight2/2 Master of Small Molecules 您边的抑制剂师www

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论